CompanyTrack
A

ALEVIN THERAPEUTICS LIMITED

Active Cambridge

Other research and experimental development on natural sciences and engineering

0 employees Website
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
A

ALEVIN THERAPEUTICS LIMITED

Other research and experimental development on natural sciences and engineering

Founded 11 Mar 2022 Active Cambridge, England 0 employees alevintherapeutics.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
Accounts Submitted 2 Dec 2024
Confirmation Statement Submitted 12 Mar 2025
Net assets £473.15K £233.45K 2024 year on year
Total assets £481.18K £289.31K 2024 year on year
Total Liabilities £8.03K £55.85K 2024 year on year
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

Hauxton House, Mill Sci Tech Park Mill Lane Hauxton Cambridge CB22 5HX England

Office ()

Cambridge, Cambridgeshire, United Kingdom, Europe

Credit Report

Discover ALEVIN THERAPEUTICS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

N/A

Net Assets

£473.15k

Decreased by £233.45k (-33%)

Total Liabilities

£8.03k

Decreased by £55.85k (-87%)

Turnover

N/A

Employees

N/A

Debt Ratio

2%

Decreased by 6 (-75%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 19,248 Shares £919k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
22 Jul 20229,272£619k£66.76
22 Jul 20222,247£150k£66.756
1 Apr 20222,728£150k£54.985
11 Mar 20225,001£0.5£0

Officers

Officers

3 active
Status
Alice Laura MacgowanDirectorBritishUnited Kingdom4920 Apr 2022Active
Sunil Rajen ShahDirectorBritishUnited Kingdom5220 Apr 2022Active
Thomas McinallyDirectorBritishEngland7011 Mar 2022Active

Shareholders

Shareholders (6)

University Of Nottingham
29.9%
724,80012 Mar 2025
Thomas Mcinally
8.3%
200,70012 Mar 2025
Simon Macdonald
6.2%
149,80012 Mar 2025

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

O2h Nominees Limited (on Behalf Of O2h Ventures Limited)

United Kingdom

Active
Notified 22 Jul 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Ownership Of Shares 50 To 75 Percent As Firm
  • Voting Rights 50 To 75 Percent
  • Voting Rights 50 To 75 Percent As Firm
  • Right To Appoint And Remove Directors As Firm

University Of Nottingham

United Kingdom

Active
Notified 22 Jul 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Ownership Of Shares 25 To 50 Percent As Firm
  • Voting Rights 25 To 50 Percent
  • Voting Rights 25 To 50 Percent As Firm
  • Right To Appoint And Remove Directors As Firm

Thomas Mcinally

Ceased 22 Jul 2022

Ceased

Simon John Fawcett Macdonald

Ceased 22 Jul 2022

Ceased

Group Structure

Group Structure

BLOKKX LTD. united kingdom
ALEVIN THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
12 Mar 2025Confirmation StatementConfirmation statement made on 2025-03-10 with updatesView(5 pages)
22 Jan 2025ResolutionResolutionsView(4 pages)
22 Jan 2025CapitalCapital Alter Shares SubdivisionView(4 pages)
10 Dec 2024Persons With Significant ControlChange to University of Nottingham as a person with significant control on 2024-12-10View(3 pages)
10 Dec 2024Persons With Significant ControlChange to O2H Nominees Limited (On Behalf of O2H Ventures Limited) as a person with significant control on 2024-12-10View(3 pages)
12 Mar 2025 Confirmation Statement

Confirmation statement made on 2025-03-10 with updates

22 Jan 2025 Resolution

Resolutions

22 Jan 2025 Capital

Capital Alter Shares Subdivision

10 Dec 2024 Persons With Significant Control

Change to University of Nottingham as a person with significant control on 2024-12-10

10 Dec 2024 Persons With Significant Control

Change to O2H Nominees Limited (On Behalf of O2H Ventures Limited) as a person with significant control on 2024-12-10

Recent Activity

Latest Activity

Confirmation statement made on 2025-03-10 with updates

11 months ago on 12 Mar 2025

Resolutions

1 years ago on 22 Jan 2025

Capital Alter Shares Subdivision

1 years ago on 22 Jan 2025

Change to University of Nottingham as a person with significant control on 2024-12-10

1 years ago on 10 Dec 2024

Change to O2H Nominees Limited (On Behalf of O2H Ventures Limited) as a person with significant control on 2024-12-10

1 years ago on 10 Dec 2024